OOIR: Observatory of International Research

Papers

(The H4-Index of Alzheimers & Dementia is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Do the extracellular vesicles excreted during neuronal cell death play a neuron‐glia signalling role in neurodegeneration.	1991
Speed of cognitive decline in biomarker stratified SCD subgroups	1650
Automating the verbal paired associates test to assess memory remotely and at scale	639
CaMKIIα signaling is required for the neuroprotective effects of Dl‐3‐n‐butylphthalide in Alzheimer’s disease	600
2021 Annual Report of Japanese Brain Bank Network for Neuroscience Research	474
Systemic and central nervous system metabolome changes associated with Ginkgo biloba treatment in non‐demented subjects	358
Characteristics of peripheral immune system in a novel App^NL‐G‐F knock‐in mouse model of Alzheimer’s disease	252
AD‐Associated Variants Directly Impair Surface Interactions Between the Hydrophobic Site of TREM2 and the Hinge Region of ApoE	246
Loss of apolipoprotein E exacerbates microglial and astrocyte reactivity to sustained systemic glucocerebrosidase inhibition	232
Validation of Mitochondria‐Targeted AD Therapeutics in Human Neuronal Cells	169
Assessment of ccf‐Mitochondrial DNA Damage in Cognitive Impairment via NGS: Health Disparities in Mexican Americans	165
Exploring Inflammasome/Cytokine/Insulin cascade as converging landscape for AD, Schizophrenia(SCHIZO), and COVID‐19 syndrome: synthesis of evidence and Post‐hoc analysis of Ginsans‐115 RCT in treatmen	161
Characterization of a mouse model as a predictive tool for human Post‐Acute Sequelae of Covid‐19	155
Trajectories of Neurological Recovery 12 Months after Hospitalization for COVID‐19: A Prospective Longitudinal Study	152
The Effect of COVID‐19 Lockdown on Dementia Caregivers in the U.S.	148
Differential roles of ApoE isoforms in regulation of inflammatory cytokine expression	147
Using an entorhinal cortex‐based virtual reality navigation task to differentiate between individuals with and without subjective cognitive decline	140
Family care partners experiences of delirium in caring for a person with dementia: Qualitative descriptive study	140
Re‐evaluation of the genetic role of a rare APOE variant (L28P; APOE^4Pittsburgh*) in late‐onset Alzheimer disease	133
Methods in Prioritizing Pathways and Targets from Expression Data	128
Ancestry‐Specific eQTL Associations in AA/NHW Alzheimer Disease Cohorts	124
Policy recommendations from the perspective of health professionals who work with people with dementia in public tertiary hospitals in China	122
Association of air quality reduction with incident dementia: Effects of natural course and hypothetical air pollutant interventions using g‐computation	119
Iron intake, brain iron, and Alzheimer’s disease among community‐dwelling older adults	117
Assessing sex differences between mid‐life cardiovascular conditions or risk factors and mid‐life cognition decline	115

Outreach and recruitment of African Americans for Alzheimer’s disease studies during the COVID‐19 pandemic	111
Association of anticholinergic medication and AD biomarkers among cognitively normal late middle‐age adults: Results from the Wisconsin Registry for Alzheimer's Prevention (WRAP)	110
Biomarker driven enrichment strategies for tau pathology in AD clinical trials	107
Comparison of remote and in‐person digital speech‐based measures of cognition	106
Measuring synaptic loss in early AD stages: Trajectories of SNAP25 and SYT1 using serial CSF sampling	103
Dementia‐inclusive radio series ‘Talkin’ About Neurodegeneration'—A look under the dementia umbrella and a follow‐on series to award‐winning ‘Voyage Around My Brain’ on NearFM	95
Associations between CSF proteins and medial temporal lobe atrophy across the AD continuum	91
Issue Information	88
Persistent pain is associated with lower locus coeruleus integrity in older adults	88
The use of the Cognitive Change Questionnaire by community health workers as dementia screening method	85
Applications of PRESS‐MRS, MEGA‐PRESS, and pCASL to evaluate treatment effect of Kami Guibi‐tang on amnestic MCI	85
Fish intake and MRI burden of cerebrovascular disease in older adults	82
Concordance and diagnostic accuracy between Innotest and two fully automated platforms: Elecsys and Lumipulse	81
Technical performance and biotemporal stability evaluation of Olink proximity extension assay for blood‐based biomarker discovery	80
Exploring the basis of phenotypic diversity in Alzheimer’s disease	71
Tracing individual trajectory of longitudinal tau spreading in deep latent space	70
Meaning from tragedy: exploring attitudes toward dementia patient participation in research	69
Identifying individuals with non‐AD co‐pathologies: A precision medicine approach to clinical trials in sporadic AD	69
The troubles and needs of family caregivers of older adults with moderate to severe dementia	64
Feasibility of the occupational therapy protocol TAP (Tailored Activity Program) for the management of behaviors in a dementia hospital unit: Preliminary results from a pilot study	63
Impairment of auditory integration in subjective cognitive decline, amnestic mild cognitive impairment, and Alzheimer’s disease	63
Cognitive correlations with amyloid, tau and neurodegeneration PET across the Alzheimer’s disease age spectrum	62
Combination of baicalein and trans‐chalcone synergistically reduces amyloid beta and its toxicity in yeast	62
Cortical microstructure is associated with tau burden and predicts cognitive decline and clinical progression in healthy older adults	61
Despite heightened risk of cognitive decline, no evidence of local atrophy in people with subjective cognitive decline compared to normal controls in ADNI	59
Networking analysis for neuroimaging and genetic markers in Alzheimer's disease	59
The chauffeur who banged cars happily: an interesting case of rapidly progressive strategic infarct dementia	58
The relationship between cortical grey to white matter signal contrast (GWC) and tau pathology in atypical AD	58
The heterogeneity of subjective cognitive decline: A data‐driven approach on a population‐based sample	56
Functional connectivity measurements in APP/PS‐1 mice revealed hypo‐connectivity with transient hyper‐connectivity	56
Trajectories of self‐rated concerns in individuals developing cognitive decline	56